natural killer cells

NEW HAVEN, Conn. — September 28, 2026 Arvinas, Inc. announced that the first participant has been dosed in the...

LAWRENCEVILLE, N.J. — September 10, 2026 IMUNON, Inc. announced a Cooperative Research and Development Agreement (CRADA) with the National...

SOUTH SAN FRANCISCO, California — September 8, 2026 Nkarta, Inc. announced that three scientific presentations featuring NKX019 have been...

SAN DIEGO, California — September 8, 2026 Artiva Biotherapeutics, Inc. announced planned clinical data disclosures and development milestones for...

OSLO, Norway, July 13, 2026 Zelluna announced that the first patient has been dosed in the ZIMA-101 Phase 1...

CULVER CITY, Calif., June 1, 2026 ImmunityBio announced new clinical and comparative data from its ANKTIVA® (nogapendekin alfa inbakicept-pmln)...

Santa Ana, California, December 3, 2025 — NKGen Biotech has issued an official statement regarding new board appointments at...